Liste des publications parues en 2023

Articles

Recherche fondamentale

  • Masliantsev K, Mordrel M, Banor T, Desette A, Godet J, Milin S, Wager M, Karayan-Tapon L, Guichet PO. Yes-Associated Protein Nuclear Translocation Is Regulated by Epidermal Growth Factor Receptor Activation Through Phosphatase and Tensin Homolog/AKT Axis in Glioblastomas. Lab Invest. 2023 May ; 103(5):100053. doi: 10.1016/j.labinv.2022.100053 [↗]. PMID: 36801645 [↗].
  • Desette A, Guichet PO, Emambux S, Masliantsev K, Cortes U, Ndiaye B, Milin S, George S, Faigner M, Tisserand J, Gaillard A, Brot S, Wager M, Tougeron D, Karayan-Tapon L. Deciphering brain metastasis stem cell properties from colorectal cancer highlights specific stemness signature and shared molecular features. Cell Mol Gastroenterol Hepatol. 2023 Jul 21 ; S2352-345X(23)00137-6. doi: 10.1016/j.jcmgh.2023.07.008 [↗]. PMID: 37482243 [↗].

Recherche clinique & translationnelle

  • Evrard C, Ingrand P, Rochelle T, Martel M, Tachon G, Flores N, Randrian V, Ferru A, Haineaux PA, Goujon JM, Karayan-Tapon L, Tougeron D. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study. Dig Liver Dis. 2023 Jun 10 ; S1590-8658(23)00524-8. doi: 10.1016/j.dld.2023.03.011 [↗]. PMID: 37308396 [↗].
  • Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial. JAMA Oncol. 2023 Aug 3 ; e232761. doi: 10.1001/jamaoncol.2023.2761 [↗]. PMID: 37535388 [↗] ; PMCID: PMC10401392 [↗].
  • Péraudeau E, Renoux B, Emambux S, Poinot P, Châtre R, Thoreau F, Riss Yaw B, Tougeron D, Clarhaut J, Papot S. Combination of Targeted Therapies for Colorectal Cancer Treatment. Mol Pharm. 2023 Aug 14. doi: 10.1021/acs.molpharmaceut.3c00224 [↗]. PMID: 37579031 [↗].